Polyphor Ltd.

Industry · 11 registered clinical trials.

Status	Trial	Phase	Started
Terminated	Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas Pneumonia	Phase 3	2018-10-22
Terminated	Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa Pneumonia	Phase 3	2018-03-23
Completed	DDI Study to Investigate Interaction Between Amikacin and POL7080 Healthy	Phase 1	2016-04-01
Terminated	Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis. Bronchiectasis, Lower Respiratory Infection	Phase 2	2013-12-01
Completed	Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa Ventilator Associated Pneumonia, Lower Respiratory Infection	Phase 2	2013-10-01
Completed	CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI) Large Reperfused ST-Elevation Myocardial Infarction	Phase 2	2013-07-01
Completed	Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer Metastatic Breast Cancer	Phase 1	2013-06-01
Completed	Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment Renal Impairment	Phase 1	2013-04-01
Completed	Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malig Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Remission, Chronic Myelogenous Leukemia (CML)	Phase 1 / Phase 2	2012-04-01
Completed	Safety and Efficacy of POL6326 for Mobilization of Hematopoietic Stem Cells in Healthy Volunteers Healthy	Phase 1	2012-02-01
Completed	Exploratory Study on POL6326 in Stem Cell Mobilization Multiple Myeloma	Phase 2	2009-04-01